Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Starling Oncology, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +22 vs. Q3 2021
- Shares held
- 2.75M
- +2.75M vs. Q3 2021
- Total value
- $2.56M
- +$2.56M vs. Q3 2021
- New holders
- 22
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STLNW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $163.5K |
| Q1 2026 | 11 | $172.4K |
| Q4 2025 | 11 | $465.1K |
| Q3 2025 | 12 | $469.0K |
| Q2 2025 | 11 | $195.4K |
| Q1 2025 | 11 | $94.9K |
| Q4 2024 | 14 | $19.0K |
| Q3 2024 | 15 | $52.0K |
| Q2 2024 | 18 | $108.0K |
| Q1 2024 | 15 | $827.5K |
| Q4 2023 | 16 | $806.9K |
| Q3 2023 | 15 | $406.9K |
| Q2 2023 | 15 | $132.4K |
| Q1 2023 | 17 | $232.3K |
| Q4 2022 | 14 | $346.4K |
| Q3 2022 | 14 | $1.78M |
| Q2 2022 | 13 | $1.61M |
| Q1 2022 | 14 | $3.90M |
| Q4 2021 | 22 | $2.56M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Starling Oncology, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 3,957 | $3.00K | 0.00% | +3,957 | New |
| UBS Group AG | 4,372 | $3.00K | 0.00% | +4,372 | New |
| DuPont Capital Management Corp | 12,500 | $9.00K | 0.00% | +12,500 | New |
| Virtu Financial LLC | 12,603 | $9.00K | 0.00% | +12,603 | New |
| HBK Investments L P | 14,000 | $10.0K | 0.00% | +14,000 | New |
| CSS LLC | 14,136 | $10.0K | 0.00% | +14,136 | New |
| Tenor Capital Management Co., L.P. | 25,000 | $17.0K | 0.00% | +25,000 | New |
| Alpine Global Management, LLC | 25,024 | $17.0K | 0.00% | +25,024 | New |
| Greenhaven Road Investment Management, L.P. | 47,003 | $32.0K | 0.01% | +47,003 | New |
| Park West Asset Management LLC | 62,200 | $43.0K | 0.00% | +62,200 | New |
| Bulldog Investors, LLP | 75,267 | $52.0K | 0.01% | +75,267 | New |
| Healthcare of Ontario Pension Plan Trust Fund | 87,500 | $60.0K | 0.00% | +87,500 | New |
| Man Group plc | 94,740 | $65.0K | 0.00% | +94,740 | New |
| JPMorgan Chase & Co | – | $73.0K | 0.00% | – | New |
| Wolverine Asset Management LLC | 113,286 | $78.0K | 0.00% | +113,286 | New |
| Union Square Park Capital Management, LLC | 120,000 | $83.0K | 0.05% | +120,000 | New |
| Difesa Capital Management, LP | 125,000 | $86.0K | 0.06% | +125,000 | New |
| Jefferies Group LLC | 175,000 | $120.8K | 0.00% | +175,000 | New |
| Davidson Kempner Capital Management LP | 318,710 | $220.0K | 0.00% | +318,710 | New |
| Highbridge Capital Management LLC | – | $710.0K | 0.02% | – | New |
| Deerfield Management Company, L.P. (Series C) | 1,250,000 | $863.0K | 0.02% | +1,250,000 | New |
| LMR Partners LLP | 165,418 | – | – | +165,418 | New |